A multicenter phase II study of docetaxel (D) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). A preliminary analysis.

被引：0
|
作者：
Giannakakis, T [1 ]
Kakolyris, S [1 ]
Papadouris, S [1 ]
Mavroudis, D [1 ]
Kalbakis, K [1 ]
Souglakos, J [1 ]
Agelaki, S [1 ]
Passam, F [1 ]
Mixaki, J [1 ]
Georgoulias, V [1 ]
机构：
[1] Greek Cooperat Grp Lung Canc, Heraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547P
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [41] Carboplatin (CBDCA), ifosfamide (IFX) and etoposide (VP) in advanced non small cell lung cancer (NSCLC): A phase II trial
    Candamio, S
    Menendez, MD
    Irigoyen, A
    Baron, FJ
    Vazquez, F
    Cueva, JF
    Huidobro, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1087 - 1087
  • [42] Vinorelbine and carboplatin in elderly patients with metastatic non-small cell lung cancer (NSCLC): A multicenter phase II study
    Deppermann, Karl-Matthias
    Ukena, Dieter
    von Pawel, Joachim
    Koschel, Gabriele
    Reck, Martin
    Serke, Monika
    Huber, Rudolf-Maria
    Eberhardt, Wilfried
    Niederle, Norbert
    ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [43] Phase 2 study of bortezomib±docetaxel in advanced non-small cell lung cancer (NSCLC)
    Fanucchi, M
    Fossella, F
    Fidias, P
    Natale, R
    Belt, R
    Govindan, R
    Raez, L
    Schiller, J
    Kashala, O
    Kelly, K
    LUNG CANCER, 2005, 49 : S30 - S30
  • [44] Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer: Final results
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Son, C.
    Kim, K.
    Lee, K.
    Yang, D.
    Lee, S.
    Choi, P.
    Cho, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase II study of taxol and carboplatin in advanced non-small cell lung cancer
    Ginopoulos, P
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 503 - 507
  • [48] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in patients (pts) with locally advanced non-small cell lung cancer (NSCLC)
    Aerts, J
    van Klaveren, R
    Surmont, V
    Senan, S
    Tan, Y
    Vernhout, R
    van Wijhe, G
    Verhoeven, G
    Hoogsteden, H
    van Meerbeeck, J
    LUNG CANCER, 2005, 49 : S164 - S164
  • [49] Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer
    Takeda, K
    Takifuji, N
    Uejima, H
    Yoshimura, N
    Terakawa, K
    Negoro, S
    LUNG CANCER, 2002, 38 (03) : 303 - 308
  • [50] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
12345